A combination of two diabetes drugs is more effective than one in treating 10-17-year-olds recently diagnosed with type 2 diabetes, according to researchers at Washington University in St. Louis who participated in a multicenter clinical trial funded by the National Institutes of Health (NIH).
The Washington University School of Medicine segment of the trial was led by Neil H. White, M.D., professor of pediatrics and of medicine and director of the Pediatric Clinical Research Unit and a diabetes specialist at St. Louis Children’s Hospital.
The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) study is the first major comparative effectiveness trial for the treatment of type 2 diabetes in young people using the diabetes drugs metformin and rosiglitazone. Results of the study appeared April 29 in the New England Journal of Medicine.
The study is the largest to date to provide information about the serious nature of type 2 diabetes in youth and to compare the efficacy of the available treatments, White says.
The featured article was originally published at Washington University Newsroom: Two drugs better than one to treat youth with type 2 diabetes